Farringdon Capital »

United Therapeutics Corporation shares owned by Farringdon Capital

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Farringdon Capital from 13F filings

Historical chart of Farringdon Capital investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Farringdon Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Farringdon Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.8M 3.6k 487.25
2025-09-30 $260k 619 419.21
2024-12-31 $292k 828 352.84

More positions owned by Farringdon Capital

Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Ishares Tr Trust Ishare 0-1 (SHV)
Ishares Ethereum Tr SHS (ETHA)
Haleon Spon Ads (HLN)
Broadcom (AVGO)
Bitwise Bitcoin Etf Tr Shs Ben Int (BITB)
Ark 21shares Bitcoin Etf Shs Ben Int (ARKB)
Vaneck Bitcoin Etf Sh Ben Int (HODL)
Invesco Galaxy Bitcoin Etf Com Shs Ben Int (BTCO)
Zillow Group Cl C Cap Stk (Z)
National Grid Sponsored Adr Ne (NGG)
Alphabet Cap Stk Cl C (GOOG)
Pearson Sponsored Adr (PSO)
Meta Platforms Cl A (META)
HSBC HLDGS Spon Adr New (HSBC)

View all positions for Farringdon Capital

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
venBio Select Advisor
Renaissance Technologies
State Street Corporation
Wellington Management Company
Geode Capital Management
AQR Capital Management
Assetmark
Invesco
Norges Bank Investment Management
Dimensional Fund Advisors
Susquehanna International
Henderson Group
Citadel Advisors

View all funds holding United Therapeutics Corporation